Corresponding Author: Misha Rosenbach, MD, Department of Dermatology, University of Pennsylvania, 3600 Spruce St, 2 Maloney, Philadelphia, PA 19104 (Misha.Rosenbach@pennmedicine.upenn.edu).
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank David E. Elder, MBChB (University of Pennsylvania Perelman School of Medicine) for his work in evaluating the biopsy and highlighting histopathologic features important for determining this patient’s diagnosis. We thank the patient for granting permission to publish this information.
2.Bolognia
JL , Schaffer
JV , Cerroni
L . Dermatology. Elsevier; 2017.
5.Hanada
Y , Berbari
EF , Steckelberg
JM . Minocycline-induced cutaneous hyperpigmentation in an orthopedic patient population.
open forum infect dis. 2016;3(1):ofv107. doi:
10.1093/ofid/ofv107PubMedGoogle Scholar 6.Roberts
G , Capell
HA . The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.
J Rheumatol. 2006;33(7):1254-1257.
PubMedGoogle Scholar 7.Okada
N , Sato
S , Sasou
T , Aoyama
M , Nishida
K , Yoshikawa
K . Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: observations using fluorescence microscopy and high-performance liquid chromatography.
Br J Dermatol. 1993;129(4):403-407. doi:
10.1111/j.1365-2133.1993.tb03166.xPubMedGoogle ScholarCrossref